Prime Medicine Inc (PRME)

Jun 18, 2025

Prime Medicine’s SWOT analysis: gene editing firm faces cash crunch amid promising tech - Investing.com

Jun 18, 2025

Jun 17, 2025

Prime Medicine’s Technological Edge and Strategic Positioning Highlighted as Key Investment Opportunity - TipRanks

Jun 17, 2025

Jun 16, 2025

Prime Medicine, Inc. (NYSE:PRME) Major Shareholder Acquires $33,600.00 in Stock - MarketBeat

Jun 16, 2025

Jun 14, 2025

Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty - MSN

Jun 14, 2025

Jun 08, 2025

Two Sigma Advisers LP Sells 76,700 Shares of Prime Medicine, Inc. (NYSE:PRME) - Defense World

Jun 08, 2025

Jun 07, 2025

Prime Medicine, Inc. (NYSE:PRME) Receives $10.08 Average PT from Brokerages - Defense World

Jun 07, 2025

Jun 06, 2025

Prime Medicine stock plummets amid restructuring and leadership changes - MSN

Jun 06, 2025

Jun 06, 2025

Bank of America Corp DE Trims Stock Holdings in Prime Medicine, Inc. (NYSE:PRME) - Defense World

Jun 06, 2025

Jun 06, 2025

Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace

Jun 06, 2025

Jun 05, 2025

Prime Medicine Elects Directors at Annual Meeting - TipRanks

Jun 05, 2025

Jun 03, 2025

20,096 Shares in Prime Medicine, Inc. (NYSE:PRME) Bought by BNP Paribas Financial Markets - Defense World

Jun 03, 2025

Jun 03, 2025

Jane Street Group LLC Boosts Stock Position in Prime Medicine, Inc. (NYSE:PRME) - Defense World

Jun 03, 2025

Jun 02, 2025

Deutsche Bank AG Cuts Position in Prime Medicine, Inc. (NYSE:PRME) - Defense World

Jun 02, 2025

May 31, 2025

Altria, Prime Medicine, US Steel, DLocal, Prothena: Trending by Analysts - TipRanks

May 31, 2025

May 29, 2025

Prime Medicine Announces Key Presentations at Two Major Healthcare Investor Conferences in June - Stock Titan

May 29, 2025

May 29, 2025

Prime Medicine to Participate in Upcoming Investor Conferences - The Manila Times

May 29, 2025

May 28, 2025

Prime Medicine’s (PRME) Neutral Rating Reaffirmed at Citigroup - Defense World

May 28, 2025

May 27, 2025

Citigroup Downgrades Prime Medicine (PRME) Amid Significant Pric - GuruFocus

May 27, 2025

May 27, 2025

Prime Medicine’s SWOT analysis: gene editing firm shifts focus, stock faces challenges By Investing.com - Investing.com South Africa

May 27, 2025

May 27, 2025

Citigroup Downgrades Prime Medicine to Neutral From Buy, Adjusts Price Target to $1.50 From $10 - marketscreener.com

May 27, 2025

May 27, 2025

Prime Medicine’s SWOT analysis: gene editing firm shifts focus, stock faces challenges - Investing.com Canada

May 27, 2025

May 26, 2025

Prime Medicine (PRME) Downgraded by Citi with Reduced Price Targ - GuruFocus

May 26, 2025

May 26, 2025

Prime Medicine (PRME) Downgraded by Citi with Reduced Price Target | PRME Stock News - GuruFocus

May 26, 2025

May 26, 2025

Prime Medicine downgraded to Neutral from Buy at Citi - TipRanks

May 26, 2025

May 26, 2025

Hold Rating for Prime Medicine, Inc. Amid Financial Uncertainties and Strategic Adjustments - TipRanks

May 26, 2025

May 25, 2025

Prime Medicine (NYSE:PRME) Earns "Neutral" Rating from JPMorgan Chase & Co. - MarketBeat

May 25, 2025

May 24, 2025

Prime Medicine FY2025 EPS Estimate Raised by Chardan Capital - Defense World

May 24, 2025

May 23, 2025

Hold Rating on Prime Medicine, Inc. Amid Strategic Shifts and Financial Reevaluation - TipRanks

May 23, 2025

May 23, 2025

Critical Analysis: Prime Medicine (NYSE:PRME) and Vigil Neuroscience (NASDAQ:VIGL) - Defense World

May 23, 2025

May 22, 2025

Prime Medicine Executives Make Bold Stock Purchases! - TipRanks

May 22, 2025

May 22, 2025

Insider Buying: Ann Lee Acquires 100,000 Shares of Prime Medicine Inc (PRME) - GuruFocus

May 22, 2025

May 22, 2025

Prime Medicine Executives Make Significant Stock Purchases - TradingView

May 22, 2025

May 22, 2025

Prime Medicine CEO Acquires 125,000 Shares - TradingView

May 22, 2025

May 22, 2025

Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More - TradingView

May 22, 2025

May 21, 2025

Finance Watch: Prime, Kyverna, Allogene And More Announce Job Cuts - insights.citeline.com

May 21, 2025

May 20, 2025

Prime Medicine Announces Layoffs, CEO Transition: Retail Gets More Bullish - MSN

May 20, 2025

May 20, 2025

Prime Medicine Cuts Workforce By 25% In Strategic Shift - Finimize

May 20, 2025

May 20, 2025

CEO among 25% of staff out the door at cash-strapped Prime - The Pharma Letter

May 20, 2025

May 20, 2025

Prime Medicine (PRME) Sees Price Target Adjustment by JMP Securities | PRME Stock News - GuruFocus

May 20, 2025

May 20, 2025

This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

May 20, 2025

May 20, 2025

Prime Medicine (PRME) Receives Downgrade from JP Morgan | PRME Stock News - GuruFocus

May 20, 2025

May 20, 2025

PRME: Prime Medicine Downgraded to Neutral by HC Wainwright & Co - GuruFocus

May 20, 2025

May 20, 2025

Prime Medicine downgraded to Neutral from Buy at H.C. Wainwright - TipRanks

May 20, 2025

May 20, 2025

Prime Medicine (PRME) Faces Downgrade Amid Strategic Shift | PRM - GuruFocus

May 20, 2025

May 20, 2025

Prime Medicine (PRME) Adjusts Strategy Amid Leadership Changes | - GuruFocus

May 20, 2025

May 20, 2025

Prime Medicine price target lowered to $6 from $10 at Citizens JMP - TipRanks

May 20, 2025

May 20, 2025

Prime Medicine, Inc.: Hold Rating Amid Strategic Restructuring and Long-term Uncertainty - TipRanks

May 20, 2025

May 19, 2025

Prime Medicine refocuses on liver disease, leadership changes By Investing.com - Investing.com South Africa

May 19, 2025

May 19, 2025

PRME Downgraded by JPMorgan Amid Strategic Shift | PRME Stock News - GuruFocus

May 19, 2025